Algoclinic
ActiveSummary
Algoclinic has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,101 and a net result of €2,101. Its solvency ranks better than 20% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Directors
2 directors, no change since 2026
VAN DEN BERGE Wouter
CurrentDirector · since 27-06-2024
Florian Demuynck
CurrentAdditional director · since 01-05-2026
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Mandate history
2 people since 2024, 2 in office
- Board
| Name | Functions and periods |
|---|---|
| VAN DEN BERGE Wouter |
|
| Florian Demuynck |
|
Owners and capital
Capital and shareholders
Shareholders according to the deeds
At incorporation
act of 27-06-2024 ↗
- VAN DEN BERGE Wouter 50 shares (100%)
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 27-06-2024 Incorporation · €1,000 · 50 shares